Immunology/Inflammation related Antibody
Anti-CD19 Antibody (Tafasitamab) is an Fc-engineered humanized monoclonal antibody that specifically targets the CD19 antigen on B lymphocytes. The compound mediates potent antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) by enhanced binding to Fcgamma receptors on effector cells, thereby directly inducing cell death and depleting malignant B cells. It serves as a pharmacological tool for investigating diffuse large B-cell lymphoma (DLBCL) and other B-cell malignancies.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
UNK sgRNA CRISPR Lentivector (Human) (Target 2)
Lentiviral mouse Htr7 shRNA (UAS) - Lentiviral mouse Htr7 shRNA (UAS) (100)
Lentiviral human NUDT2 sgRNA gene knockout kit - Lentiviral human NUDT2 sgRNA gene knockout kit (plasmid)
